Areas of Research & Innovation
Advancing clinical diabetology through cutting-edge telemedicine, automated technology, novel therapeutics, and patient-centered clinical epidemiology.
Pioneering Scientific Breakthroughs
Our multidisciplinary research team explores multifaceted clinical avenues designed to translate laboratory and digital discoveries directly into superior patient outcomes.
Pioneered 1997
10,000+ Monitored Lives
Telemedicine & DTMS®
Pioneered in 1997, the Diabetes Tele Management System (DTMS®) is a globally recognized multidisciplinary telemedicine platform providing round-the-clock decision support, glucose telemetry, and individualized therapy titration.
- 24/7 continuous decision support & real-time glucose telemetry
- Statistically proven long-term HbA1c reduction maintained over 10+ years
- Significant reduction in severe hypoglycemic episodes and hospitalizations
- Published in Diabetes Technology & Therapeutics and International Diabetes journals
Automated Delivery
90+ Tech Publications
Advanced Diabetes Technologies & AID
Leading clinical investigations on Automated Insulin Delivery (AID / Artificial Pancreas), Continuous Glucose Monitoring (CGM/FGM), smart insulin pens, and sensor-augmented pump therapy to revolutionize Type 1 and Type 2 diabetes care.
- Closed-loop and hybrid artificial pancreas clinical evaluations
- Time-in-Range (TIR) optimization and glycemic variability studies
- Connected smart health ecosystems, wearables, and predictive algorithms
- International clinical consensus guidelines on insulin pump & sensor therapy
Next-Gen Therapeutics
Phase II-IV Trials
Novel Pharmacotherapy & Incretins
Rigorous clinical trials evaluating next-generation GLP-1 receptor agonists, dual GIP/GLP-1 receptor co-agonists, SGLT-2 inhibitors, and novel once-weekly basal insulins for glycemic efficacy and cardiorenal protection.
- Cardiovascular and renal outcomes research in diverse patient cohorts
- Metabolic profiling, non-alcoholic fatty liver disease (MASLD), & weight management agents
- Once-weekly basal insulins (Icodec, Efsitora) real-world clinical evaluation
- Evidence-based clinical recommendations for South Asian populations
Longitudinal Registries
390+ Papers
Clinical Epidemiology & Prevention
Longitudinal observational registries analyzing South Asian diabetes phenotypes, early-onset Type 2 diabetes patterns, microvascular complications prevention, and population-level digital screening strategies.
- South Asian phenotype characterization & young-onset diabetes registries
- Retinopathy, nephropathy, and diabetic neuropathy longitudinal outcomes
- Comprehensive lifestyle interventions & structured diabetes self-management education
- Real-world data contributing to national and international health policies
Collaborate on Scientific Research
We welcome global pharmaceutical sponsors, academic institutions, principal investigators, and biotechnology innovators to partner with our CDSCO & ICMR-registered Clinical Research Unit.
From Digital Telemetry to Patient Bedside
Our 4-stage scientific framework bridges cutting-edge discovery with direct clinical care and international policy impact.
Digital Telemetry & Data
Capturing real-time CGM streams, device telemetry, and patient-reported clinical parameters through DTMS®.
GCP Clinical Trials
Conducting rigorous Phase II-IV global pharmacological, technological, and behavioral clinical investigations.
Real-World Evidence
Analyzing long-term longitudinal registries to optimize individual glycemic targets and prevent complications.
Global Guidelines & Policy
Authoring landmark peer-reviewed publications and international consensus guidelines (ADA, EASD, RSSDI).
Our Hospital & Research Branches
Accessible, world-class comprehensive diabetes care and clinical research across 5 strategic locations.